Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2008

View Archived Issues

BMD increased by percutaneous injection of novel GEM-OS2 in preclinical studies

Bone formation enhanced with GSK's calcium-sensing receptor antagonist ronacaleret

New agents for diabetic nephropathy disclosed in recent Kowa patent

Recent Wyeth patent reports novel bazedoxifene prodrugs

AEterna completes enrollment in phase III study of LHRH antagonist cetrorelix in BPH

Boehringer and Evec sign license agreement for fully human therapeutic antibody program

Athera and Dyax sign collaboration agreement for antibodies in cardiovascular inflammation

Calabar initiates phase II study of Xalieve in xerostomia

AEterna initiates second stage of patient recruitment in phase II ovarian cancer trial of AEZS-108

Novel agents for cardiovascular disorders described in recent patent literature

deCODE files IND for DG-071 for Alzheimer's disease and other cognitive disorders

Genentech, Roche and Glycart sign development agreement for monoclonal antibody GA-101

Genentech reports case of PML in patient who received Raptiva for more than 4 years

Crucell receives contract from NIAID to advance Ebola and Marburg vaccines

DSMB recommends continuation of BioMS Medical's MAESTRO-03 trial of dirucotide in MS

Lilly and Deciphera sign agreement for B-Raf kinase inhibitors for cancer treatments

Astellas launches Irribow in Japan for diarrhea-predominant IBS

CombinatoRx reports top-line results from phase IIb Synavive study

Dendreon presents interim data from phase III Provenge trial

PDC Biotech reports progress on preclinical program for PDC-31

Rifaximin achieves significant results in prevention of hepatic encephalopathy

Unigene initiates phase I study for oral PTH

Lilly to acquire ImClone Systems

R&D highlights from the UBS Global Life Sciences Conference in New York: Vectura Group

Novel pharmacological chaperones identified as promising agents to treat phenylketonuria

Adjuvant therapy with catumaxomab safe in phase II gastric cancer study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...